Prolira BV is a technology-driven company based in Utrecht, the Netherlands, specializing in the development of medical devices for the early detection of delirium, a condition characterized by acute brain failure. Founded in 2015 as a spin-off from the University Medical Center Utrecht, Prolira's flagship product, DeltaScan, utilizes electroencephalography (EEG) to analyze brain activity. The DeltaScan system consists of a single-use electrode patch, known as the DeltaScan Patch, and a monitoring module, the DeltaScan Monitor, which processes the EEG data. The company's management team collaborates with technical, market introduction, and clinical evaluation teams, supported by an advisory board and a clinical evaluation board comprised of leading academic medical centers in Europe.